TY - JOUR T1 - CX3CR1 as a Respiratory Syncytial Virus Receptor in Pediatric Human Lung JF - medRxiv DO - 10.1101/19002394 SP - 19002394 AU - Christopher S. Anderson AU - Chin-Yi Chu AU - Qian Wang AU - Jared A. Mereness AU - Yue Ren AU - Kathy Donlon AU - Soumyaroop Bhattacharya AU - Ravi S. Misra AU - Edward E. Walsh AU - Gloria S. Pryhuber AU - Thomas J. Mariani Y1 - 2019/01/01 UR - http://medrxiv.org/content/early/2019/09/16/19002394.abstract N2 - BACKGROUND Data on the host factors that contribute to infection of young children by Respiratory Syncytial Virus (RSV) are limited. The human chemokine receptor, CX3CR1, has recently been implicated as an RSV receptor. Here we evaluate a role for CX3CR1 in pediatric lung RSV infections.METHODS CX3CR1 transcript levels in the upper and lower pediatric airways were assessed. Tissue localization and cell specific expression was confirmed using in situ hybridization and immunohistochemistry. The role of CX3CR1 in RSV infection was also investigated using a novel physiological model of pediatric epithelial cells.RESULTS Low levels of CX3CR1 transcript were often, but not always, expressed in both upper (62%) and lower airways (36%) of pediatric subjects. CX3CR1 transcript and protein expression was detected in epithelial cells of normal human pediatric lung tissues. CX3CR1 expression was readily detected on primary cultures of differentiated pediatric/infant human lung epithelial cells. RSV demonstrated preferential infection of CX3CR1 positive cells, and blocking CX3CR1/RSV interaction significantly decreased viral load.CONCLUSION CX3CR1 is present in the airways of pediatric subjects where it may serve as a receptor for RSV infection. Furthermore, CX3CR1 appears to play a mechanistic role in mediating viral infection of pediatric airway epithelial cells in vitro.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the NIH/NIAID HHSN272201200005C, NIH/NHLB I1U01HL122700 and the University of Rochester Pulmonary training grant T32-HL066988.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesAll data is included within the manuscript. ER -